España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Compugen
CGEN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.53
0.01
0.66%
At close: -
$1.58
0.05
3.27%
After Hours: Dec 20, 7:27 PM EDT
Get Report
Comment
Compugen (CGEN) Forecast
News
Earnings
Compugen (CGEN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Compugen (NASDAQ:CGEN) Stock
Compugen Stock (NASDAQ: CGEN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 27, 2024
Compugen Expands Its Intellectual Property Po...
Benzinga Newsdesk
Tuesday, November 12, 2024
Compugen Q3 2024 GAAP EPS $0.01 Misses $0.06 ...
Benzinga Newsdesk
Earnings Scheduled For November 12, 2024
Benzinga Insights
Tuesday, August 06, 2024
Compugen Q2 EPS $(0.02) Beats $(0.07) Estimat...
Benzinga Newsdesk
Monday, July 29, 2024
Compugen Announces FDA Has Cleared The IND Fo...
Benzinga Newsdesk
Thursday, July 18, 2024
Alterity Up on Interim Data From Advance MSA Study
Zacks
Wednesday, July 17, 2024
Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data
Zacks
Wednesday, July 10, 2024
UniQure Soars on New Huntington's Disease Study Data
Zacks
Friday, June 28, 2024
Merck's New Pneumococcal Jab Capvaxive Gets CDC Panel Vote
Zacks
Thursday, June 27, 2024
Novo Nordisk's Hypertension Drug Study Fails to Meet Goal
Zacks
Tuesday, June 04, 2024
Intellia Up on Upbeat Long-Term Angioedema Study Data
Zacks
Thursday, May 30, 2024
Compugen To Receive $5M Milestone Payment Fro...
Benzinga Newsdesk
Tuesday, May 21, 2024
Truist Securities Maintains Buy on Compugen, ...
Benzinga Newsdesk
Monday, May 20, 2024
Compugen Expects Its Cash And Cash-related Ba...
Benzinga Newsdesk
Compugen Q1 2024 GAAP EPS $(0.08) Beats $(0.1...
Benzinga Newsdesk
Wednesday, May 15, 2024
Compugen Appoints David Silberman As Its New ...
Benzinga Newsdesk
Wednesday, April 10, 2024
Compugen Reports Publication Of Paper In Canc...
Benzinga Newsdesk
Friday, March 08, 2024
Truist Securities Maintains Buy on Compugen, ...
Benzinga Newsdesk
Tuesday, March 05, 2024
Compugen shares are trading lower after the c...
Benzinga Newsdesk
Compugen Q4 EPS $0.11 Misses $0.23 Estimate, ...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
Earnings Preview For Compugen
Benzinga Insights
Monday, January 08, 2024
Earlier Compugen Announced It Regained Compli...
Benzinga Newsdesk
Compugen To Receive $10M Milestone Payment Fo...
Benzinga Newsdesk
Tuesday, December 19, 2023
Stifel Maintains Buy on Compugen, Raises Pric...
Benzinga Newsdesk
Crude Oil Rises Over 1%; Biodexa Pharmaceuticals Shares Plunge
Avi Kapoor
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
Dow Jumps 150 Points; FactSet Shares Rise After Q1 Results
Avi Kapoor
Why Is Cancer Immunotherapy-Focused Compugen Stock Is Trading Higher Today?
Vandana Singh
Compugen Shares Resume Trade
Benzinga Newsdesk
US Stocks Higher; Accenture Issues Weak Sales Outlook
Avi Kapoor
Compugen Shares Halted On Circuit Breaker To ...
Benzinga Newsdesk
Compugen shares are trading higher after Gile...
Benzinga Newsdesk
Market-Moving News for December 19th
Benzinga Newsdesk
Compugen Says It Will Be Eligible To Receive ...
Benzinga Newsdesk
Gilead Sciences Expects License Transaction W...
Benzinga Newsdesk
Gilead Sciences, Compugen Ink Exclusive Lice...
Benzinga Newsdesk
Tuesday, November 07, 2023
Compugen Q3 EPS $(0.11) Misses $(0.09) Estima...
Benzinga Newsdesk
Earnings Scheduled For November 7, 2023
Benzinga Insights
Monday, November 06, 2023
Compugen Says COM701 (Anti-PVRIG) Mediates An...
Benzinga Newsdesk
Tuesday, October 31, 2023
Compugen To Present New Data At SITC 2023 Sug...
Benzinga Newsdesk
Monday, October 02, 2023
Compugen Says Japanese Patent Office Granted ...
Benzinga Newsdesk
Wednesday, September 27, 2023
Compugen To Present New Clinical And Pre-Clin...
Benzinga Newsdesk
Wednesday, August 23, 2023
Truist Securities Reiterates Buy on Compugen,...
Benzinga Newsdesk
Watching Compugen; Truist Securities Out With...
Happy Mohamed
Monday, August 07, 2023
5 Analysts Have This to Say About Compugen
Benzinga Insights
EF Hutton Reiterates Buy on Compugen, Maintai...
Benzinga Newsdesk
Compugen Q2 EPS $(0.11) Beats $(0.13) Estimat...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2023
Benzinga Insights
Friday, August 04, 2023
Compugen Earnings Preview
Benzinga Insights
Show More